{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "5937839",
  "DateCompleted": {
    "Year": "1966",
    "Month": "09",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0008-4824",
      "JournalIssue": {
        "Volume": "11 Suppl",
        "PubDate": {
          "Year": "1966"
        }
      },
      "Title": "Canadian Psychiatric Association journal",
      "ISOAbbreviation": "Can Psychiatr Assoc J"
    },
    "ArticleTitle": "The metabolism of norepinephrine in depressions. Differences and effects of therapies.",
    "Pagination": {
      "StartPage": "50",
      "EndPage": "60",
      "MedlinePgn": "Suppl:50-60"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosenblatt",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chanley",
        "ForeName": "J D",
        "Initials": "JD"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Canada",
    "MedlineTA": "Can Psychiatr Assoc J",
    "NlmUniqueID": "0414266",
    "ISSNLinking": "0008-4824"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "10028-17-8",
      "NameOfSubstance": "Tritium"
    },
    {
      "RegistryNumber": "1806D8D52K",
      "NameOfSubstance": "Amitriptyline"
    },
    {
      "RegistryNumber": "6RZ6XEZ3CR",
      "NameOfSubstance": "Chlordiazepoxide"
    },
    {
      "RegistryNumber": "OGG85SX4E4",
      "NameOfSubstance": "Imipramine"
    },
    {
      "RegistryNumber": "U42B7VYA4P",
      "NameOfSubstance": "Chlorpromazine"
    },
    {
      "RegistryNumber": "X4W3ENH1CV",
      "NameOfSubstance": "Norepinephrine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amitriptyline"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Chlordiazepoxide"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Chlorpromazine"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Electroconvulsive Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Imipramine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "In Vitro Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Norepinephrine"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Schizophrenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tritium"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Urine"
    }
  ]
}